AI Bubble or Sustainable Growth? Here Are 2 Healthcare Companies Harnessing AI for the Long Term.

Group 1: AI in Healthcare - Nvidia has become the largest component of the S&P 500, highlighting the growing importance of AI technology across various sectors, including healthcare [1] - Bristol Myers Squibb has partnered with Microsoft to leverage AI for earlier lung cancer diagnosis and treatment, utilizing Microsoft's imaging technology prevalent in 80% of U.S. hospitals [2][3] - Intuitive Surgical is integrating real-time AI imaging technology into its surgical robots, enhancing the capability to perform lung surgeries by addressing the challenge of moving organs [6][7] Group 2: Company Performance and Investment Potential - Bristol Myers Squibb offers a 4.6% dividend yield and a price-to-earnings ratio of 18, making it an attractive option for long-term income investors, especially with its AI initiatives [5] - Intuitive Surgical has a high P/E ratio of 70 but is experiencing rapid growth, with a 13% increase in da Vinci surgical robots installed and a 19% rise in surgeries performed using these robots [6] - The potential for AI to revolutionize surgical procedures could lead to significant growth opportunities for Intuitive Surgical in the future [7]